Skip to main content
OpenTrials

Clinical trial condition

Thoracic Neoplasms

Explore clinical trials studying Thoracic Neoplasms. Study availability and eligibility vary by location and protocol.

7,997 public trials 1,823 recruiting studies
Refine in advanced search Browse all conditions

Thoracic Neoplasms trial results

Recruiting

A Study of PRMT5 Inhibitor BAY 3713372 in Participants With MTAP-deleted Solid Tumors

NCT06914128

Conditions
Astrocytoma, Bronchial Neoplasms, Carcinoma, Bronchogenic, +17 more
Locations
  • UAB O'Neal Comprehensive Cancer Center - The Kirklin Clinic of UAB Hospital Birmingham, Alabama, United States
  • City of Hope - Duarte Cancer Center Duarte, California, United States
  • UCLA Health Bowyer Oncology Center Los Angeles, California, United States
  • UCSF Helen Diller Medical Center at Parnassus Heights - Neurology San Francisco, California, United States
View all 60 locations
View Trial Details
Recruiting

Gilteritinib for the Treatment of ALK NSCLC

NCT06225427

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +9 more
Locations
  • Cedars-Sinai Medical Center Los Angeles, California, United States
  • Georgetown University Washington D.C., District of Columbia, United States
  • University of Michigan Comprehensive Cancer Center Ann Arbor, Michigan, United States
View Trial Details
Recruiting

Prediction Augmented Screening Initiative

NCT06538636

Conditions
Lung Cancer, Lung Cancer Screening, Lung Diseases, +6 more
Locations
  • VA Bedford HealthCare System, Bedford, MA Bedford, Massachusetts, United States
  • VA Boston Healthcare System Jamaica Plain Campus, Jamaica Plain, MA Boston, Massachusetts, United States
  • VA Ann Arbor Healthcare System, Ann Arbor, MI Ann Arbor, Michigan, United States
  • Ralph H. Johnson VA Medical Center, Charleston, SC Charleston, South Carolina, United States
View Trial Details
Recruiting

A Study of Gilteritinib in Adults With Advanced ALK-positive Non-small Cell Lung Cancer (NSCLC)

NCT07140016

Conditions
Anaplastic Lymphoma Kinase (ALK) Positive, Bronchial Neoplasms, Carcinoma, Bronchogenic, +9 more
Locations
  • Providence Medical Foundation - Fullerton - Virginia K. Crosson Cancer Center Fullerton, California, United States
  • University of California - Irvine Orange, California, United States
  • Emory Winship Cancer Institute Atlanta, Georgia, United States
  • OSF Health Care Peoria, Illinois, United States
View all 16 locations
View Trial Details
Recruiting

Subcutaneous Tarlatamab in Participants With Extensive Stage Small Cell Lung Cancer (DeLLphi-308)

NCT06598306

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Extensive Stage Small Cell Lung Cancer, +8 more
Locations
  • University of Southern California, Norris Comprehensive Cancer Center Los Angeles, California, United States
  • University of Illinois Chicago Chicago, Illinois, United States
  • Trinity Health Saint Joseph Mercy Ann Arbor Ann Arbor, Michigan, United States
  • Avera Cancer Institute Sioux Falls, South Dakota, United States
View all 31 locations
View Trial Details
Recruiting

Pembrolizumab (MK-3475) Plus Investigational Agents in Resectable Non-small Cell Lung Cancer (NSCLC) (MK-3475-01E/KEYMAKER-U01)

NCT06788912

Conditions
Lung Diseases, Lung Neoplasm Malignant, Lung Neoplasms, +6 more
Locations
  • Southern Cancer Center (SCC) ( Site 8004) Daphne, Alabama, United States
  • Sansum Clinic (Ridley Tree) ( Site 8012) Santa Barbara, California, United States
  • Rocky Mountain Cancer Centers (RMCC) ( Site 8011) Lone Tree, Colorado, United States
  • MedStar Franklin Square Medical Center ( Site 0033) Baltimore, Maryland, United States
View all 38 locations
View Trial Details
Recruiting

The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)

NCT04585750

Conditions
Adnexal Diseases, Advanced Malignant Neoplasm, Advanced Solid Tumor, +81 more
Locations
  • University of California Irvine Chao Family Comprehensive Cancer Center Irvine, California, United States
  • University of San Diego Moores Cancer Center La Jolla, California, United States
  • UCLA Jonsson Comprehensive Cancer Center Los Angeles, California, United States
  • USC Norris Comprehensive Cancer Center Los Angeles, California, United States
View all 77 locations
View Trial Details

Related conditions